Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Prothrombin Complex Concentrate in Cardiac Surgery: A Systematic Review and Meta-Analysis.

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G.

Ann Thorac Surg. 2019 Apr;107(4):1275-1283. doi: 10.1016/j.athoracsur.2018.10.013. Epub 2018 Nov 17. Review.

PMID:
30458156
2.

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, De Marco M, Stevens CAT, Akram A, Freiberger T, Hovingh GK, Kastelein JJP, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Al-Khnifsawi M, AlKindi FA, Alnouri F, Alonso R, Al-Rasadi K, Al-Sarraf A, Ashavaid TF, Binder CJ, Bogsrud MP, Bourbon M, Bruckert E, Chlebus K, Corral P, Descamps O, Durst R, Ezhov M, Fras Z, Genest J, Groselj U, Harada-Shiba M, Kayikcioglu M, Lalic K, Lam CSP, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi HM, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Postadzhiyan A, Reda A, Reiner Ž, Sadoh WE, Sahebkar A, Shehab A, Shek AB, Stoll M, Su TC, Subramaniam T, Susekov AV, Symeonides P, Tilney M, Tomlinson B, Truong TH, Tselepis AD, Tybjærg-Hansen A, Vázquez-Cárdenas A, Viigimaa M, Vohnout B, Widén E, Yamashita S, Banach M, Gaita D, Jiang L, Nilsson L, Santos LE, Schunkert H, Tokgözoğlu L, Car J, Catapano AL, Ray KK; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.

Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.

3.

Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.

Bamimore MA, Zaid A, Banerjee Y, Al-Sarraf A, Abifadel M, Seidah NG, Al-Waili K, Al-Rasadi K, Awan Z.

J Clin Lipidol. 2015 Mar-Apr;9(2):187-94. doi: 10.1016/j.jacl.2014.11.008. Epub 2014 Nov 29. Review.

PMID:
25911074
4.

Exercise in a healthy heart program: a cohort study.

Meikle J, Al-Sarraf A, Li M, Grierson K, Frohlich J.

Clin Med Insights Cardiol. 2013 Sep 15;7:145-51. doi: 10.4137/CMC.S12654. eCollection 2013.

5.

Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol.

Juren AJ, Sarwal G, Al-Sarraf A, Vrablik M, Chan D, Humphries KH, Frohlich JJ.

J Clin Lipidol. 2013 May-Jun;7(3):194-8. doi: 10.1016/j.jacl.2013.02.003. Epub 2013 Feb 26.

PMID:
23725918
6.

Safety of statin therapy in patients with mitochondrial diseases.

Hannah-Shmouni F, Al-Sarraf A, Frohlich J, Mezei MM, Sirrs S, Mattman A.

J Clin Lipidol. 2013 Mar-Apr;7(2):182. doi: 10.1016/j.jacl.2012.08.003. Epub 2012 Aug 10. No abstract available.

PMID:
23415441
7.

Paediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia.

Sarwal G, Al-Sarraf A, Frohlich J.

BMJ Case Rep. 2012 Nov 1;2012. pii: bcr2012007579. doi: 10.1136/bcr-2012-007579.

8.

Regional and national familial hypercholesterolemia registries: present international application, importance, and needs for Canada.

Al-Sarraf A, Allard M, Martinka M, Frohlich J.

Can J Cardiol. 2013 Jan;29(1):6-9. doi: 10.1016/j.cjca.2012.04.019. Epub 2012 Jun 19. Review. No abstract available.

PMID:
22717249
9.

Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.

Li M, Al-Sarraf A, Mattman A, Frohlich J.

BMJ Case Rep. 2012 Apr 23;2012. pii: bcr1220115369. doi: 10.1136/bcr.12.2011.5369.

10.

Cardiovascular risk and atherosclerosis prevention.

Frohlich J, Al-Sarraf A.

Cardiovasc Pathol. 2013 Jan-Feb;22(1):16-8. doi: 10.1016/j.carpath.2012.03.001. Epub 2012 Apr 12. Review.

PMID:
22502868
11.

Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study.

Sandhu S, Al-Sarraf A, Taraboanta C, Frohlich J, Francis GA.

Lipids Health Dis. 2011 Sep 11;10:157. doi: 10.1186/1476-511X-10-157.

12.

Cholesterol efflux capacity and atherosclerosis.

Frohlich J, Al-Sarraf A.

N Engl J Med. 2011 Apr 14;364(15):1474; author reply 1474-5. doi: 10.1056/NEJMc1101853. No abstract available.

PMID:
21488780
13.

Fish odour syndrome.

Li M, Al-Sarraf A, Sinclair G, Frohlich J.

CMAJ. 2011 May 17;183(8):929-31. doi: 10.1503/cmaj.100642. Epub 2011 Mar 21. No abstract available.

14.

Statin resistant dyslipidemia in a patient treated with amiodarone.

Al-Sarraf A, Li M, Frohlich J.

BMJ Case Rep. 2011 Oct 11;2011. pii: bcr0820114620. doi: 10.1136/bcr.08.2011.4620.

15.

Central pontine myelinolysis after orthotopic liver transplant-a rare complication.

Al-Sarraf AJ, Haque M, Pudek M, Yoshida EM.

Exp Clin Transplant. 2010 Dec;8(4):321-4.

16.

Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature.

Al-Sarraf A, Al-Ghofaili K, Sullivan DR, Wasan KM, Hegele R, Frohlich J.

J Clin Lipidol. 2010 Sep-Oct;4(5):420-6. doi: 10.1016/j.jacl.2010.05.001. Epub 2010 Jun 1. Review.

PMID:
21122686
17.

Hepatic lipase deficiency in a Middle-Eastern-Arabic male.

Al Riyami N, Al-Ali AM, Al-Sarraf AJ, Hill J, Sachs-Barrable K, Hegele R, Wasan KM, Frohlich J.

BMJ Case Rep. 2010 Nov 12;2010. pii: bcr1220092589. doi: 10.1136/bcr.12.2009.2589.

18.

Bisalbuminuria detected by agarose gel electrophoresis.

Al-Sarraf A, Chow C, Garg A.

Clin Biochem. 2010 Mar;43(4-5):534-6. doi: 10.1016/j.clinbiochem.2009.12.006. Epub 2009 Dec 21. No abstract available.

PMID:
20026022
19.

Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants.

Al-Awadi KA, Kehinde EO, Loutfi I, Mojiminiyi OA, Al-Hunayan A, Abdul-Halim H, Al-Sarraf A, Memon A, Abraham MP.

Urol Res. 2008 Feb;36(1):51-60. Epub 2007 Dec 7.

PMID:
18064446
20.

Is blood transfusion harmful in patients with acute coronary syndromes?

Al-Sarraf A, Fowler RA.

CMAJ. 2005 Jan 18;172(2):182. No abstract available.

21.
22.

The role of low molecular weight dextran on platelet pulmonary trapping during endotoxin-induced shock.

al-Sarraf AA, Owunwanne A, Christenson JT.

Resuscitation. 1989 Feb;17(1):1-9.

PMID:
2467339
23.

Early and late platelet sequestration in different organs during endotoxic shock.

Al-Sarraf AA, Christenson JT, Owunwanne A.

Res Exp Med (Berl). 1988;188(1):59-66.

PMID:
3127868
24.

Volumetric measurements in endotoxic shock using single photon emission tomography (SPET).

Christenson JT, Kuikka J, Owunwanne A, Al-Sarraf A, Abdul-Dayem HM.

Nucl Med Commun. 1986 Oct;7(10):771-7.

PMID:
3492693
25.

Cerebral circulation during endotoxic shock with special emphasis on the regional cerebral blood flow in vivo.

Christenson JT, Kuikka JT, Owunwanne A, Al-Sarraf AA.

Nucl Med Commun. 1986 Jul;7(7):531-40.

PMID:
3774252
26.

Assessment of cardiopulmonary alterations in endotoxic shock.

Christenson JT, Kuikka J, Al-Sarraf AA, Owunwanne A.

Am J Physiol Imaging. 1986;1(4):181-5.

PMID:
3451759
27.

A radionuclide model for studying changes in the regional blood volumes during early endotoxic shock: an experimental model.

Christenson JT, Al-Sarraf AA, Kuikka J, Owunwanne A.

Am J Physiol Imaging. 1986;1(2):77-82.

PMID:
2837257

Supplemental Content

Loading ...
Support Center